8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jul 22, 2008)

Filed July 22, 2008For Securities:DGX

Summary

Quest Diagnostics Incorporated filed an 8-K on July 22, 2008, primarily to report its financial results for the quarter ended June 30, 2008. The filing itself does not contain the detailed financial figures but instead incorporates by reference a press release (Exhibit 99.1) that was issued on the same date. Investors should refer to this press release for specific information regarding the company's performance, revenue, profitability, and any forward-looking guidance provided for the period. This 8-K filing serves as the official notification to the SEC and the public about the company's operational and financial standing as of the end of the second quarter of 2008. The signature of Robert A. Hagemann, Senior Vice President and Chief Financial Officer, attests to the accuracy of the information presented in the accompanying press release. Investors are encouraged to review the referenced press release for a comprehensive understanding of Quest Diagnostics' financial condition and results of operations.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on July 22, 2008, to report financial results.
  • 2The report covers the quarter ended June 30, 2008.
  • 3Key financial details are provided in an attached press release (Exhibit 99.1).
  • 4The press release is incorporated by reference into the 8-K filing.
  • 5Robert A. Hagemann, SVP and CFO, signed the filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally report Quest Diagnostics Incorporated's financial results and condition for the quarter ended June 30, 2008, by referencing a press release issued on the same date.

The specific financial results for the quarter ended June 30, 2008, are detailed in the press release attached as Exhibit 99.1 to this 8-K filing. Investors should consult that document for performance data.

Robert A. Hagemann is the Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated. His signature on the 8-K filing indicates that the information presented, particularly the financial results in the referenced press release, has been reviewed and authorized by the company's senior financial management.